What is YK11?
YK11, also known as Myostin, is a preparation in the field of selective androgen receptor modulators (SARMs). It was discovered in 2011 and is an orally administered molecule with the chemical designation CAS number 1370003-76-1.
The unique feature of YK11 lies in its dual function: it partially activates androgen receptors while simultaneously acting as a myostatin inhibitor. As a result, it stimulates the production of follistatin, which in turn promotes muscle growth and increases muscle strength.
Despite the potential anabolic effects of YK11, there are concerns regarding possible side effects. These can include testosterone suppression, liver damage, and other health issues. Further research is required to confirm the safety and efficacy of YK11.
How does YK11 work?
YK11 belongs to the class of selective androgen receptor modulators, or SARMs for short, and exerts its anabolic effects through partial activation of the androgen receptors in the body. In doing so, YK11 initiates an increased release of the hormone follistatin, which in turn inhibits myostatin, a protein that limits muscle growth. This process enables a greater accumulation of muscle tissue.
Furthermore, positive effects on body composition have been observed in animal studies: YK11 not only leads to an increase in muscle mass but also improves the ratio of fat to muscle tissue. The immunomodulatory function of YK11 helps strengthen the body's response to bacterial infections and has shown an increase in survival rates in experimental models of sepsis.
Is YK11 a SARM or a steroid?
YK11 is often classified within the group of selective androgen receptor modulators (SARMs), yet its properties also make it reminiscent of steroids. This has led to discussions about whether YK11 is truly a SARM or a steroid.
It is known that YK11 possesses a pronounced anabolic effect that is even stronger than that of testosterone. This effect has made it a sought-after agent for individuals looking to build muscle mass. The mechanism of YK11 involves the blocking of myostatin, a protein that limits muscle growth. Thereby, YK11 promotes increased muscle growth.
However, YK11 is also classified as a 17alpha-methyl substance and can be taken orally – a characteristic typical of steroids. Furthermore, due to its chemical composition and mode of action, it is categorized as an anabolic-androgenic steroid in anti-doping legislation. Another steroid-like aspect is the potential suppression of the body's own testosterone synthesis, which may require a post-cycle therapy to restore hormonal balance.
Due to its anabolic effect and unresearched long-term side effects, YK11 is used only for research purposes. Therefore, its use is discouraged. Because it can be attributed to both SARMs and genuine steroids, rapid effects occur after just a few days. Moreover, it is unclear whether it might still produce androgenic side effects despite its selective orientation.
Muscle growth and muscle strength
As a myostatin inhibitor, YK-11 blocks the activity of the myostatin protein and thus effectively promotes muscle growth. In a series of animal experiments, it was observed that mice treated with YK-11 were better able to maintain their body mass during periods of illness, showing a more favorable ratio of fat to muscle mass compared to the control group. YK-11 acts as a selective androgen receptor modulator, thereby enabling targeted promotion of muscle growth.
In addition to increasing muscle mass, reports and studies also reveal significant improvements in muscle strength through the use of YK-11. The activation of androgen receptors in the muscle by YK-11 contributes to a more efficient promotion of muscle growth and strength, which could also accelerate recovery after muscular injuries and damage.
Possible side effects of YK11
Firstly, YK11 can suppress natural testosterone production, which can lead to hormonal imbalances, especially in cases of improper dosage. Because of this property, a careful assessment of the YK11 dosage is of essential importance. As a result of this hormonal disturbance, users may experience increased aggression and rises in blood pressure, which can be attributed to the androgenic effects of the steroid.
Another concern is the potential for liver toxicity with an overdose of YK11. The substance can potentially cause liver damage, which should be a serious factor for users.
Furthermore, there are reports of undesirable side effects such as hair loss, prostate enlargement, and gynecomastia, which may occur particularly in sensitive individuals. Due to the severity of these side effects, women are generally advised against using YK11.